Ironwood Pharmaceuticals, Inc.IRWDNASDAQ
Loading
Operating Income ScalingExpanding
Percentile Rank71
3Y CAGR-22.0%
5Y CAGR-3.6%
Year-over-Year Change
Profit from core business operations before interest and taxes
3Y CAGR
-22.0%/yr
Annual compound
5Y CAGR
-3.6%/yr
Recent deceleration
Percentile
P71
Within normal range
vs 5Y Ago
0.8x
Contraction
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $118.76M | +27.5% |
| 2024 | $93.12M | +109.8% |
| 2023 | $-945.43M | -477.7% |
| 2022 | $250.34M | +7.8% |
| 2021 | $232.26M | +62.5% |
| 2020 | $142.94M | +19.0% |
| 2019 | $120.12M | +150.3% |
| 2018 | $-238.89M | -208.7% |
| 2017 | $-77.39M | -49.2% |
| 2016 | $-51.87M | - |